Inhibition of cathepsin L ameliorates inflammation through the A20/NF-κB pathway in endotoxin-induced acute lung injury
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a severe inflammatory condition that remains refractory; however, its molecular mechanisms are largely unknown. Previous studies have shown numerous compounds containing 4-indolyl-2-aminopyrimidine that display strong anti-inflammatory properties. In our research, we identified that a 4-Indole-2-Arylaminopyrimidine derivative named "IAAP" suppressed lipopolysaccharide (LPS)-induced inflammation. Immunoprecipitation and liquid chromatography-tandem mass spectrometry (LC-MS/MS) identified that IAAP interacts with a lysosomal cysteine protease, cathepsin L (CTSL), and restrains its activity. The nuclear factor kappa B (NF-κB) family plays a central role in controlling innate immunity. Canonical NF-κB activation, such as stimulation with lipopolysaccharide (LPS), typically involves the degradation of A20. We observed that IAAP suppression of CTSL prevented the LPS-induced degradation of A20, thereby ameliorating NF-κB activation. This study identifies CTSL as a crucial regulator of A20/NF-κB signaling and suggests IAAP as a potential lead compound for developing drugs to treat ALI/ARDS.
Authors
- Zhouyang Li (ORCID: https://orcid.org/0000-0002-7721-0175)
- Fugui Yan (ORCID: https://orcid.org/0000-0003-3060-9805)
- Zhengtong Mao
- Huahao Shen (ORCID: https://orcid.org/0000-0001-9546-9351)
- Xingxian Zhang (ORCID: https://orcid.org/0000-0003-4474-7600)
- Yun Zhao (ORCID: https://orcid.org/0000-0001-6109-4520)
- Shiyi Yang (ORCID: https://orcid.org/0000-0002-7276-6940)
- Nanxia Xuan
- Tianpeng Chen (ORCID: https://orcid.org/0000-0001-5919-7141)
- Yang Yu (ORCID: https://orcid.org/0000-0002-6256-6697)
- Kaijun Chen (ORCID: https://orcid.org/0009-0000-4860-6608)
- Songmin Ying (ORCID: https://orcid.org/0000-0003-1770-8956)
- Zhangchu Jin
- Wen Li (ORCID: https://orcid.org/0000-0002-8805-2934)
- Min Zhang (ORCID: https://orcid.org/0000-0001-7055-6790)
- Fei Xia (ORCID: https://orcid.org/0000-0003-3998-4898)
- Zhihua Chen (ORCID: https://orcid.org/0000-0002-4390-7636)
- Yinfang Wu
- Gensheng Zhang (ORCID: https://orcid.org/0000-0001-9298-3961)
- Na Li (ORCID: https://orcid.org/0000-0003-4198-5515)
- Baoping Tian
- Jinkang Yu
- Wenbing Wang
Institutions
- State Key Laboratory of Respiratory Disease (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Zhejiang University of Technology (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- iScience
- Published
- 2024-10-04
- DOI
- https://doi.org/10.1016/j.isci.2024.111024
- Citations
- 10
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.34
Funders
- National Natural Science Foundation of China
- Zhejiang University
- Natural Science Foundation of Zhejiang Province